Liposomes and other assemblies as drugs and nano-drugs: From basic and translational research to the clinics

Journal of Controlled Release

Volumn 160, Issue 2, 2012, Pages 115-116

  Barenholz, Yechezkel ^a,b   Peer, Dan ^b  

^a HEBREW UNIVERSITY   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DOXORUBICIN; DRUG; LIPID; LIPOSOME; NANODRUG; NANOMATERIAL; NANOPARTICLE; NUCLEIC ACID; POLYMER; PROTEIN; SPHINGOLIPID; SPHINGOSINE 1 PHOSPHATE AGONIST; SPHINGOSINE DERIVATIVE; UNCLASSIFIED DRUG; VACCINE;

BIOPHYSICS; CYTOLOGY; DRUG DELIVERY SYSTEM; DRUG INDUSTRY; EDITORIAL; EMULSION; FOOD AND DRUG ADMINISTRATION; HUMAN; KNOWLEDGE; LIPID RAFT; LIPOSOMAL DELIVERY; MICELLE; MULTIPLE SCLEROSIS; NANOMEDICINE; NANOTECHNOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSLATIONAL RESEARCH;

CONGRESSES AS TOPIC; DRUG CARRIERS; LIPOSOMES; NANOMEDICINE; NANOSTRUCTURES; PHARMACEUTICAL PREPARATIONS;

EID: 84861697192     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.03.025     Document Type: Editorial

References (0)